Literature DB >> 21045545

Biophysical studies of the nucleic acid chaperone properties of the HIV-1 nucleocapsid protein.

Julien Godet1, Yves Mély.   

Abstract

The nucleocapsid protein NCp7 of HIV-1 possesses nucleic acid chaperone properties that are thought to be crucial throughout the viral life cycle. These properties promote the rearrangement of nucleic acids into their most thermodynamically stable conformations. These NCp7 properties involve two components, namely nucleic acid destabilization and activation of the annealing of complementary sequences. Biophysical techniques have been found extremely powerful to decipher the molecular mechanisms underlying these two components. We propose here an overview of the recent reports that examine the nucleic acid chaperone properties of NCp7 by these techniques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045545     DOI: 10.4161/rna.7.6.13616

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  40 in total

1.  Characterization of the inhibition mechanism of HIV-1 nucleocapsid protein chaperone activities by methylated oligoribonucleotides.

Authors:  Sergiy V Avilov; Christian Boudier; Marina Gottikh; Jean-Luc Darlix; Yves Mély
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

3.  Pulse dipolar ESR of doubly labeled mini TAR DNA and its annealing to mini TAR RNA.

Authors:  Yan Sun; Peter P Borbat; Vladimir M Grigoryants; William K Myers; Jack H Freed; Charles P Scholes
Journal:  Biophys J       Date:  2015-02-17       Impact factor: 4.033

4.  Zinc finger function of HIV-1 nucleocapsid protein is required for removal of 5'-terminal genomic RNA fragments: a paradigm for RNA removal reactions in HIV-1 reverse transcription.

Authors:  Christopher B Hergott; Mithun Mitra; Jianhui Guo; Tiyun Wu; Jennifer T Miller; Yasumasa Iwatani; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2012-11-10       Impact factor: 3.303

5.  Aromatic residue mutations reveal direct correlation between HIV-1 nucleocapsid protein's nucleic acid chaperone activity and retroviral replication.

Authors:  Hao Wu; Mithun Mitra; Micah J McCauley; James A Thomas; Ioulia Rouzina; Karin Musier-Forsyth; Mark C Williams; Robert J Gorelick
Journal:  Virus Res       Date:  2012-07-16       Impact factor: 3.303

Review 6.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

7.  Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase.

Authors:  Jiae Kim; Anne Roberts; Hua Yuan; Yong Xiong; Karen S Anderson
Journal:  J Mol Biol       Date:  2011-12-23       Impact factor: 5.469

8.  Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein.

Authors:  Elia Gamba; Mattia Mori; Lesia Kovalenko; Alessia Giannini; Alice Sosic; Francesco Saladini; Dan Fabris; Yves Mély; Barbara Gatto; Maurizio Botta
Journal:  Eur J Med Chem       Date:  2017-12-24       Impact factor: 6.514

9.  A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds.

Authors:  Stefano Ciaco; Nicolas Humbert; Eléonore Real; Christian Boudier; Oscar Francesconi; Stefano Roelens; Cristina Nativi; Carole Seguin-Devaux; Mattia Mori; Yves Mély
Journal:  ACS Med Chem Lett       Date:  2020-01-27       Impact factor: 4.345

10.  Zinc Fingers in HIV-1 Gag Precursor Are Not Equivalent for gRNA Recruitment at the Plasma Membrane.

Authors:  Emmanuel Boutant; Jeremy Bonzi; Halina Anton; Maaz Bin Nasim; Raphael Cathagne; Eléonore Réal; Denis Dujardin; Philippe Carl; Pascal Didier; Jean-Christophe Paillart; Roland Marquet; Yves Mély; Hugues de Rocquigny; Serena Bernacchi
Journal:  Biophys J       Date:  2020-06-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.